Literature DB >> 20376860

Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.

Elena Latorre-Esteves1, Oleg E Akilov, Prakash Rai, Stephen M Beverley, Tayyaba Hasan.   

Abstract

A murine model of cutaneous leishmaniasis with green fluorescent protein positive (GFP+) L. major enables the monitoring of parasitic load via measurements of GFP fluorescence intensity, allowing for a faster and more efficient way of monitoring the clinical outcome of photodynamic therapy (PDT). This model may provide new insights on the phototoxic aspects in PDT. Although PDT regimens may be somewhat different in humans, it is expected that the developed model will facilitate the optimization and clinical translation of PDT as a therapy for cutaneous leishmaniasis and the eventual development of topical PDT treatments for other granulomatous infections. ((c) 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376860      PMCID: PMC2876225          DOI: 10.1002/jbio.201000008

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  28 in total

1.  Treatment of cutaneous leishmaniasis with photodynamic therapy.

Authors:  Claes D Enk; Clemens Fritsch; Flory Jonas; Abedelmajeed Nasereddin; Arieh Ingber; Charles L Jaffe; Thomas Ruzicka
Journal:  Arch Dermatol       Date:  2003-04

Review 2.  Prospects for the use of differentiation-modulating agents as adjuvant of photodynamic therapy for proliferative dermatoses.

Authors:  Oleg E Akilov; Sachiko Kosaka; Edward V Maytin; Tayyaba Hasan
Journal:  J Dermatol       Date:  2008-04       Impact factor: 4.005

3.  The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.

Authors:  T M Sitnik; B W Henderson
Journal:  Photochem Photobiol       Date:  1998-04       Impact factor: 3.421

4.  A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.

Authors:  G F Späth; S M Beverley
Journal:  Exp Parasitol       Date:  2001-10       Impact factor: 2.011

5.  The leishmaniases. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1984

6.  Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.

Authors:  A Asilian; M Davami
Journal:  Clin Exp Dermatol       Date:  2006-06-15       Impact factor: 3.470

7.  Use of the green fluorescent protein as a marker in transfected Leishmania.

Authors:  D S Ha; J K Schwarz; S J Turco; S M Beverley
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

8.  Treatment of cutaneous leishmaniasis by photodynamic therapy.

Authors:  Kerstin Gardlo; Zuzana Horska; Claes David Enk; Lucie Rauch; Mossad Megahed; Thomas Ruzicka; Clemens Fritsch
Journal:  J Am Acad Dermatol       Date:  2003-06       Impact factor: 11.527

9.  Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.

Authors:  G M Kapler; C M Coburn; S M Beverley
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

10.  [Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality].

Authors:  K Gardlo; S Hanneken; T Ruzicka; N J Neumann
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

View more
  3 in total

1.  In vitro evaluation of photodynamic therapy using curcumin on Leishmania major and Leishmania braziliensis.

Authors:  Juliana Guerra Pinto; Letícia Correa Fontana; Marco Antonio de Oliveira; Cristina Kurachi; Leandro José Raniero; Juliana Ferreira-Strixino
Journal:  Lasers Med Sci       Date:  2016-04-07       Impact factor: 3.161

Review 2.  Drug discovery of antimicrobial photosensitizers using animal models.

Authors:  Sulbha K Sharma; Tianhong Dai; Gitika B Kharkwal; Ying-Ying Huang; Liyi Huang; Vida J Bil De Arce; George P Tegos; Michael R Hamblin
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.

Authors:  Estefania Calvo-Álvarez; Nestor Adrian Guerrero; Raquel Alvarez-Velilla; Christopher Fernández Prada; Jose María Requena; Carmen Punzón; Miguel Ángel Llamas; Francisco J Arévalo; Luis Rivas; Manuel Fresno; Yolanda Pérez-Pertejo; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.